Search bioRxiv⌕ Search

Biology subjects

Kuczma, M.

Publications and source records attributed to Kuczma, M..

2 recordsLinked to original sources

Reprogramming of alveolar macrophages by intestinal segmented filamentous bacteria protects mice from lethal bacterial pneumoniae following influenza infection

The most severe outcomes of respiratory viral infection (RVI) result from secondary bacterial infection, which RVI promotes via depletion of alveolar macrophages (AM). Colonization of the intestine by the common but non-ubiquitous commensal, segmented filamentous bacteria (SFB), reprograms AM to resist RVI-induced depletion. Hence, we examined if SFB against secondary infection by S. pneumoniae, H. influenzae, or S. aureus, following primary infection by influenza virus (IAV). Indeed, SFB colonization conferred strong post-IAV protection against these lethal bacterial pathogens. AM depletion and transplant studies indicated that SFB reprogramming these cells was necessary and sufficient for such protection. Assay of AM, ex vivo, from SFB-colonized mice argued their protection against secondary bacterial infection was not only due to their withstanding IAV-induced depletion. Rather, AM from SFB-colonized mice displayed complement-dependent increases in phagocytosis and killing of these bacteria. Furthermore, AM from SFB-colonized mice stably held their enhanced anti-bacterial phenotype even when transplanted into an inflamed interferon-rich post IAV-environment. Thus, SFB, and perhaps gut microbiota composition in general influences proneness to bacterial pneumonia, especially post-RVI. One Sentence summarySFB colonization stably changed the phenotype of alveolar macrophages resulting in sustained clearance of bacterial pathogens even amidst an inflamed interferon-rich immune suppressed lung.

immunology↗

IL-36/IL-36R Signaling Promotes CD4+ T Cell-Dependent Colitis via Pro-Inflammatory Cytokine Production

Inflammatory bowel disease (IBD) is a multifactorial, chronic disease that affects approximately 1.5 million people in the United States [1]. It presents with inflammation of the intestine with unknown etiology and its two main forms are Crohns disease (CD) and ulcerative colitis (UC). Several important factors are implicated in the pathogenesis of IBD, one being dysregulation of the immune system resulting in the accumulation and stimulation of innate and adaptive immune cells and subsequent release of soluble factors, including pro-inflammatory cytokines. One of these cytokines is a member of the IL-36 cytokine family, IL-36{gamma}, which is overexpressed in human IBD and experimental mouse models of colitis. In this study, we explored the role of IL-36{gamma} in promoting CD4+ T cell activation and cytokine secretion. We found that IL-36{gamma} stimulation of naive CD4+ T cells significantly induced IFN{gamma} expression in vitro and was associated with augmented intestinal inflammation in vivo using naive CD4+ cell transfer model of colitis. Using IFN{gamma}-/- CD4+ cells, we observed a dramatic decrease in the ability of TNF production and delayed colitis. This data not only suggests that IL-36{gamma} is a master regulator of a pro-inflammatory cytokine network involving IFN{gamma} and TNF, but also highlights the importance of targeting IL-36{gamma} and IFN{gamma} as therapeutic approaches. Our studies have broad implications in relation to targeting specific cytokines in human IBD.

immunology↗